Compare Teradyne, Inc. (TER) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teradyne, Inc. vs Tilray Brands Inc — how do they compare? Teradyne, Inc. trades at $406.03 (market cap $59.34B), while Tilray Brands Inc trades at $4.73 (market cap $649.42M). The key difference: Teradyne, Inc. is far larger — about 91.4× Tilray Brands Inc's market cap, and Teradyne, Inc. pays a 0.14% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| TER | TLRY | |
|---|---|---|
Market Cap | $59.34B | $649.42M |
Sector | Technology | Health |
52-Week High | $483.84 | $21.00 |
52-Week Low | $109.30 | $3.88 |
Enterprise Value | $59.09B | $816.55M |
Dividend Yield | 0.14% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Teradyne (TER) trades at $403.6, up 10.55% in 24 hours, near its 52-week high. The stock exhibits bullish technical signals with strong earnings beats in recent quarters, including Q2 2026 EPS of $2.47 versus $2.09 expected. Revenue growth is accelerating, driven by AI-led demand in semiconductor testing and robotics, with 2026 revenue projected at $4.5 billion. Valuation ratios are elevated, with a P/E of 52.14, reflecting high growth expectations.
The outlook remains positive due to robust AI-driven demand and record earnings, though high valuation poses a risk if growth slows. Analyst consensus is strongly bullish with a $481.63 price target. Key risks include execution challenges in scaling operations and sensitivity to semiconductor cycle downturns. Institutional buying, such as Anson Funds' purchase in Q1 2026, supports momentum.
TLRY trades at $4.77, up 7.92% in the last session, with a bullish technical signal from moving averages but mixed oscillators. The company reported record fiscal 2026 revenue of $915 million (GlobeNewsWire, July 28, 2026) but posted a net loss. Key financials show a low P/S of 0.58 and P/B of 0.4, yet profitability remains challenged with negative net income margins and ROE.
Outlook is cautiously optimistic due to revenue growth and diversification into beverages and wellness, but high execution risk persists from consistent losses and competitive pressures. Analyst sentiment is mixed with 25% buy ratings, suggesting potential upside if profitability improves, though near-term volatility is likely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
